Is There Any Point in a Corticosteroid Treatment of Intermittent Asthma?
International guidelines advocate the early introduction of inhaled corticosteroids (ICS) in all types of persistent asthma. Our study was undertaken to assess the effects of ICS on bronchial hyperresponsiveness (BHR) as a hallmark of inflammation, and to assess the symptoms, the use of rescue medic...
Saved in:
Main Authors: | Ivana Stankovic, Tatjana Pejcic, Branislava Milenkovic, Dragana Jovanovic, Milan Rancic |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2007.134 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhaled Corticosteroid Therapy Does Not Control Asthma
by: Robert L Cowie, et al.
Published: (2004-01-01) -
Predictors of Loss of Asthma Control Induced by Corticosteroid Withdrawal
by: Jose Belda, et al.
Published: (2006-01-01) -
Group theory based at any point
by: M. A. Albar, et al.
Published: (2001-01-01) -
TNF-α Dysregulation in Asthma: Relationship to Ongoing Corticosteroid Therapy
by: Susan Waserman, et al.
Published: (2000-01-01) -
Montelukast as Add-On Therapy to Inhaled Corticosteroids in the Management of Asthma (The SAS Trial)
by: J Mark FitzGerald, et al.
Published: (2009-01-01)